Abnova (Taiwan) Corporation (TPE:4133)
Taiwan · Delayed Price · Currency is TWD 23.05
+0.05 (0.22%)
Mar 24, 2026, 1:30 PM CST
Abnova (Taiwan) Market Cap
Abnova (Taiwan) has a market cap or net worth of 1.4 billion as of March 24, 2026. Its market cap has decreased by -24.05% in one year.
Market Cap
1.40B
Enterprise Value
1.04B
Revenue
351.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.05
Market Cap Chart
Since May 27, 2008, Abnova (Taiwan)'s market cap has decreased from 2.91B to 1.40B, a decrease of -52.03%. That is a compound annual growth rate of -4.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 1.40B | 1.54% |
| Dec 31, 2025 | 1.37B | -23.44% |
| Dec 31, 2024 | 1.80B | -15.53% |
| Dec 29, 2023 | 2.13B | -14.81% |
| Dec 30, 2022 | 2.49B | -5.40% |
| Dec 30, 2021 | 2.64B | -25.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomics BioSci & Tech. | 1.83B |
| Advagene Biopharma | 1.79B |
| TaiRx | 1.70B |
| GenMont Biotech Incorporation | 1.55B |
| NeoCore Technology | 1.40B |
| Great Novel Therapeutics Biotech & Medicals | 1.34B |
| Enimmune | 1.28B |
| Meribank Biotech | 1.25B |